Exome sequencing identified six copy number variations as a prediction model for recurrence of primary prostate cancers with distinctive prognosis
Jie Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Biaoyang Lin(Zhejiang International Studies University), Shanshan Jin(Nanjing University of Finance and Economics), Guanfeng Liu(Macquarie University), Jiajun Yan(Shaoxing People's Hospital), Yan Wang(Suizhou Central Hospital), Xiaoyan Liu(Capital Medical University), Hongwei Zhang(Georgia Southern University), Lin Wang(Zhuzhou Central Hospital), Qingchong Qiu(Zhejiang University), Yanling Zhang(Xinyang Agriculture and Forestry University), Liang Ma(Zhejiang University), Na Zhao(Zhejiang University), Jili Wang(Lingnan Normal University), Mei-Ling Li(Rutgers, The State University of New Jersey), Ruifang Mao(Zhejiang University), Guoping Ren(Queen Mary University of London), Yingying Ma(Northeast Agricultural University)
Cited by 5
Related Papers
First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
|Cancer Discovery|2012|313
The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice
|Journal of Clinical Investigation|2011|227
DTCDR
|Unknown|2019|200